Your browser doesn't support javascript.
loading
Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer.
Saad, Fred; Fleshner, Neil; Pickles, Tom; Niazi, Tamim; Lukka, Himu; Pouliot, Frederic; Martins, Ilidio; Klotz, Laurence.
Affiliation
  • Saad F; Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada.
  • Fleshner N; Mount Sinai Hospital, Princess Margaret Cancer Centre (UHN), Toronto General Hospital (UHN), University of Toronto, Toronto, Ontario, Canada.
  • Pickles T; British Colombia Cancer Agency, University of British Columbia (UBC), Vancouver, British Columbia.
  • Niazi T; McGill University, Montreal, Quebec, Canada.
  • Lukka H; McMaster University, Hamilton, Ontario, Canada.
  • Pouliot F; Laval University, Quebec City, Quebec, Canada.
  • Martins I; Kaleidoscope Strategic Inc., Toronto, Ontario, Canada.
  • Klotz L; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
J Urol ; 204(3): 416-426, 2020 Sep.
Article in En | MEDLINE | ID: mdl-32096678
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Testosterone / Androgen Antagonists Type of study: Diagnostic_studies / Prognostic_studies / Systematic_reviews Limits: Humans / Male Language: En Journal: J Urol Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Testosterone / Androgen Antagonists Type of study: Diagnostic_studies / Prognostic_studies / Systematic_reviews Limits: Humans / Male Language: En Journal: J Urol Year: 2020 Document type: Article Affiliation country: